Science 37 Holdings Inc (NAS:SNCE)
$ 5.75 0 (0%) Market Cap: 34.67 Mil Enterprise Value: -21.16 Mil PE Ratio: 0 PB Ratio: 0.66 GF Score: 20/100

Science 37 Holdings Inc at Robert W Baird Global Healthcare Conference Transcript

Sep 13, 2022 / 07:45PM GMT
Release Date Price: $38 (+2.15%)
Eric Coldwell
Robert W. Baird & Co. - Analyst

Good afternoon, everyone. My name is Eric Coldwell. I cover pharma services for Baird, and it's our pleasure to have Science 37 with us this afternoon. I want to introduce David Coman, CEO; Mike Zaranek, CFO. We've known each other a while. We've known each other a long while; long history in the pharma services and related world.

Great pleasure to have the company with us today. I'm a lifetime CRO guy who has watched this slow inevitable transition to decentralized trial activity. And it's been really interesting, really fun -- cool might be the right word to watch the evolution of DCT specialists over the last few years.

And then what should prove to be a very big catalyst with COVID and how it's helping transition the world coupled with all the technology investments that have been made as well as capabilities to do trials in a more decentralized, flexible format.

I'm going to let our good friend Dave here just kick us off, go right into a presentation and then we'll jump in with Q&A. And really happy to have you with

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot